Berna Biotech acquires Rhein Biotech for US$257 M
Business Review Editor
Abstract
Berna Biotech entered into an agreement to acquire Rhein Biotech for €279 M (US$257 M) in cash and stock. Berna is to offer 1.42 Berna shares and €33.75 in cash for each Rhein Biotech stock.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.